On July 16, Colgate-Palmolive rose 3.07% in regular trading, trading at $94.255/share, with turnover of $74.45 million. The rally was driven by a wave of analyst upgrades, with JPMorgan raising its price target from $96 to $104 while maintaining an Overweight rating on the same day.

The JPMorgan upgrade followed Citigroup's move on July 14, which lifted its target from $105 to $110 with a Buy rating maintained. Earlier in July, Piper Sandler raised its target to $96 from $92, and Wells Fargo adjusted to $95 from $92. The consensus mean price target has now risen to $97.78, well above the current trading price, reflecting broad institutional confidence in the company's growth trajectory.

On the fundamental side, Colgate-Palmolive reported Q1 adjusted EPS of $0.97, beating the $0.94 consensus estimate, while organic sales growth rebounded to approximately 3.5%. Morgan Stanley noted that the company's difficult period is now behind it, supported by solid pricing power and 45% exposure to faster-growing emerging markets. The company's next earnings report is scheduled for July 31.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)